Long
LONG $XXII BASED ON NEWS AND OPTIONS ACTIVITY
GREAT TECHNICAL SETUP WITH INSTITUTIONAL BUYERS COMING IN
BUILD A LONG TERM POSITION AMEX:XXII
GREAT PULL BACK TODAY AND CHANCE TO GET IN AROUND $3 LEVEL
It received a major boost because of commentary from the Food and Drug Administration on July 28 that called for a new comprehensive plan on tobacco and nicotine regulation. The quick summary of the FDA's press release: It called for a reduction in nicotine in cigarettes to non-addictive levels, which would play right into the hands of 22nd Century Group, as a biotech company focused on reducing nicotine levels in tobacco.
BUILD A LONG TERM POSITION AMEX:XXII
GREAT PULL BACK TODAY AND CHANCE TO GET IN AROUND $3 LEVEL
It received a major boost because of commentary from the Food and Drug Administration on July 28 that called for a new comprehensive plan on tobacco and nicotine regulation. The quick summary of the FDA's press release: It called for a reduction in nicotine in cigarettes to non-addictive levels, which would play right into the hands of 22nd Century Group, as a biotech company focused on reducing nicotine levels in tobacco.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.